Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 164 results for "sun pharma"

Today's picks: From Vedenta to Sun Pharma, hot stocks to watch on Tuesday
Business Standard

Today's picks: From Vedenta to Sun Pharma, hot stocks to watch...

Keep a stop at Rs 1,465 and go short Devangshu Datta Last Updated at April 24, 2018 00:26 IST Nifty Current: 1 0,585 (fut: 10,585) Target: NA Stop-long positions at 10,500. Stop-short positions at 10,650. Big moves could go till 10,700, 10,475. A long 10,600c ... Business Standard, 7 hours ago

94 images for sun pharma

Money Control, 1 week ago
Business Standard, 6 hours ago
Money Control, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Business Standard, 1 month ago
Sify, 1 month ago
Money Control, 1 month ago
Money Control

Sensex, Nifty end flat; M&M, Sun Pharma top gainers

Indian markets ended flat on Monday snapping earlier losses. Both Sensex and Nifty traded above 2-month high. At the close, the benchmark 30-share index, BSE Sensex added 35.19 or 0.10% at 34,450.77 with 12 components posting rise. Meanwhile, the broad based ...
 Myiris20 hours ago Market Live: Sensex extends gains, Nifty comfortably above 10,400; Nifty PSU Bank up 1%  Money Control1 month ago Market Update: ICICI Bank falls over 2%, drags Bank Nifty lower; Ashok Leyland hits new 52-week high  Money Control1 month ago
Business Standard

Sun Pharma announces USFDA approval of ILUMYA drug

announced that the U.S. Food and Drug Administration (FDA) has approved ILUMYA (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. ILUMYAâ„¢ selectively ...
 Myiris1 month ago Sun Pharma gains on USFDA nod for psoriasis drug Ilumya  Business Standard1 month ago Sun Pharma gets US FDA nod for its specialty psoriasis drug Ilumya  Money Control1 month ago Sun Pharma gets approval for psoriasis drug Ilumya, its first biologic drug  Business Standard1 month ago

PCI chief hints at uniform pharmacy syllabus across all colleges

Pharmacy education in the country is all set to undergo a revamp. With the Pharmacy Council of India (PCI) aiming to take admissions online from next year, the syllabus will now be industry relevant. Announcing the same, Dr B Suresh, President, PCI who was in ...
 DNA4 weeks ago Pharma shares in focus; Cipla, Sun Pharma surge over 5%  Business Standard2 months ago Stocks in the news: Lupin, PNB, Sun Pharma, Mangalam Organics, Torrent Pharma, Tata Motors  Money Control2 months ago
Money Control

Market Update: Nifty pharma outperforms led by Sun Pharma, Dr Reddy#39;s, MMTC zooms 13%; IOC at 52-week low

The market breadth was in favour of the advances with 1188 stocks advancing while 430 declined and 395 remained unchanged. On the other hand, in the BSE, 1491 stocks advanced and 628 declined and 106 remained unchanged.
 Money Control1 month ago Market Update: CNX Pharma outshines, jumps over 2% led by Sun Pharma; BoB up 2%, Jubilant Life falls 7%  Money Control1 month ago

Buy Blue Star, Sun Pharma, LIC Housing Finance: Ashwani Gujral

Ashwani Gujral of recommends buying Blue Star, Sun Pharma and LIC Housing Finance.
 Money Control1 month ago Buy Persistent Systems, Sun Pharma, Adani Ports, Bajaj Finance, JSPL, NIIT Technologies: Ashwani Gujral  Money Control2 months ago
Money Control

Buy Sun Pharma; target of Rs 675: Motilal Oswal

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 675 in its research report dated March 06, 2018.
 Money Control1 month ago
Business Standard

Sun Pharma will be watched after Q3 results

Sun Pharmaceutical Industries' (Sun Pharma) consolidated net profit fell 75.17% to Rs 365.39 crore on 16.04% decline in total revenue from operations to Rs 6653.23 crore in Q3 December 2017 over Q3 December 2016. The results were announced after market hours ...
 Business Standard2 months ago Sun Pharma slips after weak Q3 earnings  Business Standard2 months ago Sun Pharma Q3 net profit plunges 75% to Rs 3.6 bn on weak US sales  Business Standard2 months ago
Money Today

Sensex pares losses, rises over 100 pts ahead of US Fed meet

The BSE Sensex was trading 145.49 points higher, led by value buying in recently-hammered IT, bank and pharma stocks, ahead of the US Fed policy meeting scheduled later in the day.The market shrugged off early losses despite global weakness. IT stocks led the ...
 Business Standard1 month ago Sensex rises 441 points, Nifty at 10,599; Sun Pharma, Dr Reddy's, Infosys top gainers  Money Today2 months ago Sensex rises over 100 points, Nifty nears 10,600  Business Standard6 days ago Sensex rises over 100 points on firm global cues, Nifty tops 10,400  Deccan Herald2 weeks ago
Business Standard

10 years of pharmaceutical sector: Controls, regulations stymie growth

It has also been a decade of major mergers and acquisitions, the most noteworthy one perhaps being the Sun Pharma-Ranbaxy deal Sohini Das | Ahmedabad Last Updated at March 21, 2018 02:21 IST The past 10 years have been eventful for pharma. The domestic market ...
 Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less